If calculated concentration differs from intended, adjust dose draw volume to maintain microgram delivery accuracy rather than discarding the vial
doi: 10.1096/fj.00-0176com
Precision will be enhanced by baseline phenotypeguided stratification (microbiome, metabolome, immune signatures), dietmicrobe matching, and digital adherence support
Direct 5-AR inhibition is how steroid-derived hair loss drugs like Finasteride and Dutasteride work
The IRS and health plan administrators recognize medications from regulated 503A compounders as legitimate prescription products, making them eligible for HSA and FSA reimbursement just like brand-name or generic alternatives
GLP-1 (Glucagon-like Peptide-1) is a natural incretin hormone that: Stimulates insulin secretion (when glucose is high) Suppresses glucagon release Slows gastric emptying Increases satiety reducing food intake Why GLP-1 Therapy Stands Out Glycemic Control Lowers HbA1c by ~11.5% with minimal hypoglycemia risk Weight Loss 515 kg depending on drug/dose (semaglutide leads the way) Cardiovascular Protection Reduced major CV events (MACE) in trials like LEADER, SUSTAIN, REWIND Renal Protection Slows progression of diabetic kidney disease Convenience Available as daily or weekly injections and even oral semaglutide Key Clinical Trials LEADER (Liraglutide) CV mortality & MACE SUSTAIN-6 (Semaglutide) CV events & strong weight loss REWIND (Dulaglutide) CV protection even in lower-risk populations STEP Trials (Semaglutide) Double-digit weight reduction in obesity The Bigger Picture GLP-1 therapy goes beyond insulin and beyond diabetes
